11th Annual meeting of the EBMT: European Cooperative Group by Th. Büchner (auth.), W. Hinterberger, A. J. Barrett, K.

By Th. Büchner (auth.), W. Hinterberger, A. J. Barrett, K. Lechner, E. Deutsch (eds.)

Show description

Read Online or Download 11th Annual meeting of the EBMT: European Cooperative Group for Bone Marrow Transplantation PDF

Similar european books

Reforming the European Commission (Palgrave Studies in European Union Politics)

Analyses the impression of the managerial reforms of the ecu fee. In 1999 the resignation of the varsity of Commissioners caused the implementation of a White Paper which indexed ninety eight measures to overtake the best way the fee did enterprise. Ten years later what influence have the reforms had at the eu fee and eu governance?

Börsen in Transformationsökonomien: Rolle, Effizienz und strategische Optionen

Während sich die Börsen in den mittel- und osteuropäischen Transformationsökonomien in den vergangenen Jahren im Aufbau befanden, wandelten sich die westeuropäischen Börsen von nationalen Monopolisten zu professionellen Dienst-leistern. Bei diesem Vorgang wirkte der Wettbewerb zwischen den unterschiedlichen Börsenplätzen als Katalysator und löste eine Konsolidierungswelle aus.

Extra resources for 11th Annual meeting of the EBMT: European Cooperative Group for Bone Marrow Transplantation

Example text

DISCUSSION These data indicate that neoplastic cells may survive and be detected up to several weeks after BMT without' evidence of persisting or recurring leukemia. Moreover, sequential chromosome studies have not allowed to observe neoplastic cells any more up to 70-200 days after their detection. Lawler et Al. demonstrated that recipient cells may still be detected in the bone marrow some weeks after BMT for acute leukemia, without signs of relapse (I). We think that mechanisms other than cell destruction (immunological?

We had individualized two groups of patients : 1) Poor risk acute leukemia : 11 patients (Phl chromosome, secondary leukemia of breast cancer, partial remission, second or subsequent remission). The results are poor (6 deaths, 3 relapses (meningeal and medullary), 2 CR (3 months+, 4 months+)). 2) Standard risk ( first complete remission) : 13 patients (5 ALL, 8 ANLL). 1 relapse at 14th month posl-graft ~LLl), 1 death of liver veino-occlusive disease. The all 11 remain in complete remission, 2 at 20 months + after graft (median 13 months).

Ol). * Marrow cleansing was not associated with improvement both from DFS and survival anolysis, neither in CRl nor in CR2. Althouqh the difference is not statistically siqnificant, there seems to be a trend in favour of autoqraftinq with non purqed marrow in patients in CR1. l)(not statistical1y significant). D - COMPARISON BETWEEN ALL AND ANLL : By DFS analysis, results were significant1y better for ANLL (79% versus 50%, on day 560 with a plateau until1 day RR7 for both. p (. OJ). 10 7 nucleated cells) - Also, as a consequence of the precited criteria, all these patients were treated by teams reportinq more than 10 ABMT.

Download PDF sample

Rated 4.85 of 5 – based on 34 votes

Published by admin